TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Scanfarma AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
10,184
|
9,980
|
10,382 |
| Financial expenses |
0
|
6
|
1 |
| Earnings before taxes |
-3,190
|
750
|
558 |
| EBITDA |
-3,170
|
719
|
556 |
| Total assets |
4,395
|
7,515
|
8,000 |
| Current assets |
4,164
|
7,260
|
8,000 |
| Current liabilities |
938
|
879
|
1,457 |
| Equity capital |
1,450
|
4,605
|
4,128 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
3
|
5
|
6 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
33.0%
|
61.3%
|
51.6% |
| Turnover per employee |
3,395
|
1,996
|
1,730 |
| Profit as a percentage of turnover |
-31.3%
|
7.5%
|
5.4% |
| Return on assets (ROA) |
-72.6%
|
10.1%
|
7.0% |
| Current ratio |
443.9%
|
825.9%
|
549.1% |
| Return on equity (ROE) |
-220.0%
|
16.3%
|
13.5% |
| Change turnover |
204
|
-402
|
-1,282 |
| Change turnover % |
2%
|
-4%
|
-11% |
| Chg. No. of employees |
-2
|
-1
|
-1 |
| Chg. No. of employees % |
-40%
|
-17%
|
-14% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.